Virtual Medicinal Product (VMP) - Palivizumab 100mg powder and solvent for solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Palivizumab 100mg powder and solvent for solution for injection vials Start Date 09-06-2004 End Date
Previous Name Previous Name Palivizumab 100mg injection vials and diluent Start Date 02-09-2003 End Date 08-06-2004
Abbreviated Name Abbreviated Name Palivizumab 100mg inj vials Start Date 01-05-2009
Previous Abbreviated Name Palivizumab 100mg pdr & solv for soln for inj vials Previous Start Date 13-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
vial
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.intramuscular
Free From
null
Non-availability Indicator
Actual Products not Available
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
J06BD01
BNF Start Date End Date
Current BNF 05030500 Start Date 04-04-2022 End Date
Previous BNF 05030500 Start Date 23-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36023911000001103 29-10-2018
324887003 02-09-2003 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Palivizumab Based on Ingredient Substance 100 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial